Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling

Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling

US Patent 9475839 · Granted Oct 25, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-BCMA chimeric antigen receptors2024
Anti-BCMA chimeric antigen receptors2022
Peptide inhibition of CCR3-mediated diseases or conditions2021
Anti-BCMA chimeric antigen receptors2021
Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial2019
Peptide inhibition of CCR3-mediated diseases or conditions2019
Peptide-based stat inhibitor2017
Peptide-based stat inhibitor2017
Self-assembling nanoparticles composed of transmembrane peptides and their appli2016
Lipopeptide inhibitors of RAS oncoproteins2016
Synthetic peptide inhibitors of Wnt pathway2015
Synthetic peptide inhibitors of Wnt pathway2015